| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935317A Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof |
| 01/05/2011 | CN101935316A Quinazoline compound and application thereof |
| 01/05/2011 | CN101935306A New diketone piperazidine-like derivative and application thereof |
| 01/05/2011 | CN101935295A Method for extracting active ingredients from papaya seeds |
| 01/05/2011 | CN101934068A Preparation method of thymopetidum injection |
| 01/05/2011 | CN101934066A Application of actinomycin-class compound actinomycin V in preparing drug capable of resisting breast cancer |
| 01/05/2011 | CN101934058A Hard capsules for radiotherapy and chemotherapy process of cancers |
| 01/05/2011 | CN101934056A Traditional Chinese medicine for treating and preventing tumor and production method thereof |
| 01/05/2011 | CN101934054A Traditional Chinese medicine preparation for treating hysteromyoma |
| 01/05/2011 | CN101934025A Traditional Chinese medicine for clearing away heat and toxic material |
| 01/05/2011 | CN101933964A Application of conyza blinii total saponins for preparing anti-neoplastic drug |
| 01/05/2011 | CN101933956A Common macrothelypteris extract with anti-tumor effects and preparation method thereof |
| 01/05/2011 | CN101933950A Application of Trametes robiniophila Murr aqueous extract |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101933923A Cancer treatments |
| 01/05/2011 | CN101933920A Application of 3,15-dicarbonyl gibberellic acid methyl ester in reversing tumor multidrug resistance |
| 01/05/2011 | CN101933917A Application of Hyperforin derivant in preparing drugs |
| 01/05/2011 | CN101933916A Application of gallic acid in preparing anti-HPV medicine |
| 01/05/2011 | CN101933912A Preparation technology of tryptanthrin sustained-release capsule and application thereof |
| 01/05/2011 | CN101933908A Preparation process of tryptanthrin sustained release tablets and application thereof |
| 01/05/2011 | CN101933904A Vinorelbine long circulation liposome preparation and preparation method thereof |
| 01/05/2011 | CN101933897A Recombinant human endostatin temperature-sensitive gel composition for injection |
| 01/05/2011 | CN101570516B Method for preparing 4-(3-chlorine-4-fluorophenylalanine)-7-methoxy-6-[3-(4-morpholinyl) propoxy] quinazoline |
| 01/05/2011 | CN101502524B Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101502523B Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101390858B Uses of loperamide hydrochloride in preparing antineoplastic medicine |
| 01/05/2011 | CN101224226B Novel clinical uses of big nilgiri nettle |
| 01/05/2011 | CN101185625B Rubitecan sustained-release implant for treating solid tumor |
| 01/05/2011 | CN101181234B Literdinun sustained-release implantation agent for curing entity tumour |
| 01/05/2011 | CN101177415B Method for preparing new crystal form of anti-cancer compound ZD1839 |
| 01/05/2011 | CN101095957B Medicinal composition including fibroblast growth factor acceptor 2 III c analogue gene |
| 01/05/2011 | CN101020059B Medicine composition containing docetaxel matter and its preparation process |
| 01/05/2011 | CN101014334B Inhibitor for the onset and progress of liver cancer to be used in hepatitis c virus-positive human liver cirrhosis patients |
| 01/04/2011 | US7865626 Raid storage subsystem using read connection information command to request WWN information for server table and adapter connection table |
| 01/04/2011 | US7863327 Chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel disease, and multiple sclerosis |
| 01/04/2011 | US7863322 Anti-cancer combinations |
| 01/04/2011 | US7863321 Anti-cancer combinations |
| 01/04/2011 | US7863320 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 01/04/2011 | US7863289 Compounds and methods for kinase modulation, and indications therefor |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | US7863278 Isethionate salt of a selective CDK4 inhibitor |
| 01/04/2011 | US7863244 Peptides |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | CA2640591C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2501388C Nitroaniline-based alkylating agents and their use as prodrugs |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2487060C Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2474343C Nsaid-containing topical formulations that demonstrate chemopreventive activity |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2459013C Proteins having effects of controlling cell migration and cell death |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2451184C Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2427750C Substituted alkanoic acids |
| 01/04/2011 | CA2416274C N-phenyl-2-pyrimidine-amine derivatives |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2381461C Lhrh antagonists having improved solubility properties |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2369427C Interferon-beta use in the treatment of ewing's family of tumors |
| 01/04/2011 | CA2361181C Her-2 binding antagonists |
| 01/04/2011 | CA2335645C Use of interferon alpha 5 in the treatment of viral liver diseases |
| 01/04/2011 | CA2317505C Enzyme catalyzed therapeutic agents |
| 01/04/2011 | CA2303338C Water soluble paclitaxel derivatives |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/30/2010 | US20100332417 Methods for the detection and quantitation of the p95 component of her2/neu (erbb2) |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331968 Zeolites for Delivery of Nitric Oxide |
| 12/30/2010 | US20100331819 Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy |
| 12/30/2010 | US20100331815 Transluminal delivery of oncoltyic viruses for cancer therapy |
| 12/30/2010 | US20100331812 Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331418 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal |
| 12/30/2010 | US20100331414 Crystal comprising (2r)-2-propyloctanoic acid and amine |
| 12/30/2010 | US20100331403 Compounds and methods for the treatment of cancer |
| 12/30/2010 | US20100331399 Polyphenol extraction process |
| 12/30/2010 | US20100331398 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applictions |
| 12/30/2010 | US20100331397 2-5a analogs and their methods of use |
| 12/30/2010 | US20100331393 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers |
| 12/30/2010 | US20100331389 Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides |
| 12/30/2010 | US20100331385 Pyrazole urea derivatives used as kinase inhibitors |
| 12/30/2010 | US20100331382 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 12/30/2010 | US20100331370 Novel isobenzofuran analogs of sclerophytin A |
| 12/30/2010 | US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 12/30/2010 | US20100331357 Pharmaceutical composition |